JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
ML-356 is an inhibitor of the thioesterase domain of fatty acid synthase with IC50 value of 334 nM.
Fatty acid synthase (FAS) is a multi-enzyme protein that catalyzes fatty acid synthesis, fatty acids are related to energy production and storage, cellular structure ,hormones biosynthesis .A number of subsequent immunohistochemically analyses showed that increased expression of FAS is a hallmark of all major cancers including those of the prostate, the breast, the colon, and the ovaries.
In prostate cancer PC-3 cells, ML-356 blocked palmitate (the final product of fatty acids synthesis) biosynthesis, indicating that ML-356 has potential to block tumor growth in vivo because FAS is up-regulated in all the major solid tumors.
Reference:1. R. Ardecky, M. P. Hedrick, P. Gosalia, et al. Selective inhibitors of FAS-TE. Probe Reports from the NIH Molecular Libraries Program (2010).